Clinical Trial Update: Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of atrial fibrillation after atrial flutter ablation using Inhibition Conversion Enzyme (ICE) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: TERMINATED